Cite
HARVARD Citation
Pivot, X. et al. (2015). In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?. Oncologist. pp. 344-350. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pivot, X. et al. (2015). In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?. Oncologist. pp. 344-350. [Online].